Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Bioorg Med Chem Lett ; 16(6): 1643-6, 2006 Mar 15.
Artigo em Inglês | MEDLINE | ID: mdl-16412636

RESUMO

A novel class of pyrimido[4,5-b]-1,4-benzoxazepines is described as inhibitors of epidermal growth factor receptor (EGFR) tyrosine kinase. Two compounds display potent EGFR inhibitory activity of less than 1 microM in cellular phosphorylation assays (IC(50) 0.47-0.69 microM) and are highly selective against a small kinase panel. Such compounds demonstrate anti-EGFR activity within a class that is different from any known EGFR inhibitor scaffolds. They also provide a basis for the design of kinase inhibitors with the desired selectivity profile.


Assuntos
Azepinas/síntese química , Azepinas/farmacologia , Receptores ErbB/antagonistas & inibidores , Inibidores de Proteínas Quinases/síntese química , Inibidores de Proteínas Quinases/farmacologia , Trifosfato de Adenosina/metabolismo , Azepinas/química , Sítios de Ligação , Proliferação de Células/efeitos dos fármacos , Células Cultivadas , Humanos , Estrutura Molecular , Fosforilação/efeitos dos fármacos , Inibidores de Proteínas Quinases/química , Proteínas Serina-Treonina Quinases/antagonistas & inibidores , Proteínas Tirosina Quinases/antagonistas & inibidores , Receptor ErbB-2/antagonistas & inibidores , Relação Estrutura-Atividade , Especificidade por Substrato
2.
Bioorg Med Chem Lett ; 15(23): 5154-9, 2005 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-16198562

RESUMO

A novel triazole-containing chemical series was shown to inhibit tubulin polymerization and cause cell cycle arrest in A431 cancer cells with EC(50) values in the single digit nanomolar range. Binding experiments demonstrated that representative active compounds of this class compete with colchicine for its binding site on tubulin. The syntheses and structure-activity relationship studies for the triazole derivatives are described herein.


Assuntos
Antineoplásicos/química , Antineoplásicos/farmacologia , Triazóis/química , Triazóis/farmacologia , Moduladores de Tubulina/química , Moduladores de Tubulina/farmacologia , Antineoplásicos/síntese química , Humanos , Microtúbulos/efeitos dos fármacos , Estrutura Molecular , Relação Estrutura-Atividade , Triazóis/síntese química , Moduladores de Tubulina/síntese química , Células Tumorais Cultivadas
3.
Artigo em Inglês | MEDLINE | ID: mdl-15663310

RESUMO

This study presents the result of using melting to recover both industrial sludge slag (the main constituent of which is calcium fluoride) and water works sludge slag as fine aggregate in cement. The main characteristics of both slag and cement mortars were measured to evaluate the feasibility of using slag as aggregate. In this study, the slag replacement ratios were 0, 10, 20, 30, 40, and 50% (w/w), and the curing periods were 7, 28, and 90 days. Slag quality was determined according to the standards of fine aggregates in the ASTM specifications, and cement mortars with various slag replacement ratios were evaluated based on their compressive strength, and Toxicity Characteristic Leaching Procedure (TCLP). The crushed slag produced in this study met the ASTM standards for fine aggregate, including gravity, unit weight, absorption, and grading, and the TCLP leached concentrations are far below existing limits, establishing the safety and suitability of slag as fine aggregate. The TCLP leached concentrations of slag and cement mortar were not significantly related to the replacement ratio, and declined with increasing curing period, revealing that the hydration strongly influenced metal leaching. The compressive strength test results of the cement mortars demonstrated that the optimal replacement ratio for maximizing compressive strength was 40%. This study also discussed the effects of replacement ratio and curing periods on cement mortars.


Assuntos
Materiais de Construção/análise , Resíduos Industriais , Metais Pesados/análise , Fluoreto de Cálcio , Força Compressiva , Resíduos Industriais/análise , Porosidade , Semicondutores , Esgotos/análise , Temperatura de Transição
4.
Science ; 303(5659): 839-42, 2004 Feb 06.
Artigo em Inglês | MEDLINE | ID: mdl-14764880

RESUMO

Translocation of the small GTP-binding protein Rac1 to the cell plasma membrane is essential for activating downstream effectors and requires integrin-mediated adhesion of cells to extracellular matrix. We report that active Rac1 binds preferentially to low-density, cholesterol-rich membranes, and specificity is determined at least in part by membrane lipids. Cell detachment triggered internalization of plasma membrane cholesterol and lipid raft markers. Preventing internalization maintained Rac1 membrane targeting and effector activation in nonadherent cells. Regulation of lipid rafts by integrin signals may regulate the location of membrane domains such as lipid rafts and thereby control domain-specific signaling events in anchorage-dependent cells.


Assuntos
Membrana Celular/metabolismo , Integrinas/metabolismo , Microdomínios da Membrana/metabolismo , Proteínas rac1 de Ligação ao GTP/metabolismo , Animais , Sítios de Ligação , Adesão Celular , Linhagem Celular , Células Cultivadas , Toxina da Cólera/metabolismo , Colesterol/metabolismo , Gangliosídeo G(M1)/metabolismo , Glicosilfosfatidilinositóis/metabolismo , Guanosina Trifosfato/metabolismo , Humanos , Integrina beta1/metabolismo , Lipossomos/metabolismo , Camundongos , Células NIH 3T3 , Ratos , Proteínas Recombinantes de Fusão/metabolismo , Transdução de Sinais , Transfecção , Proteínas rac1 de Ligação ao GTP/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA